Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 7, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry BiomarkersCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|February 10, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance CharacteristicsEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC LaboratoriesEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.Nature Reviews. Clinical Oncology|December 6, 2018
A framework for the development of effective anti-metastatic agentsRobin L Anderson, Theo Balasas, Juliana Callaghan, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in ImmunohistochemistryCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.Virchows Archiv : an International Journal of Pathology|September 29, 2016
Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBLZandra C Deans, Jose Luis Costa, Ian Cree, et al.NPJ Breast Cancer|May 22, 2020
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trialsJan Hudeček, Leonie Voorwerk, Maartje van Seijen, et al.NPJ Breast Cancer|May 16, 2020
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerZuzana Kos, Elvire Roblin, Rim S Kim, et al.Pageof 2